Cargando…
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis
INTRODUCTION: Prevention of lymphocyte apoptosis by caspase inhibition has been proposed as a novel treatment approach in sepsis. However, it has not been clearly demonstrated that caspase inhibitors improve survival in sepsis models when dosed post-insult. Also, there are concerns that caspase inhi...
Autores principales: | Weber, Peter, Wang, Ping, Maddens, Stephane, Wang, Paul SH, Wu, Rongqian, Miksa, Michael, Dong, Weifeng, Mortimore, Michael, Golec, Julian MC, Charlton, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784364/ https://www.ncbi.nlm.nih.gov/pubmed/19740426 http://dx.doi.org/10.1186/cc8041 |
Ejemplares similares
-
VX-166, a novel potent small molecule caspase inhibitor, as a promising new treatment for sepsis
por: Weber, P, et al.
Publicado: (2006) -
Pivotal Role of the α(2A)-Adrenoceptor in Producing Inflammation and Organ Injury in a Rat Model of Sepsis
por: Miksa, Michael, et al.
Publicado: (2009) -
Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release
por: Zhou, Mian, et al.
Publicado: (2008) -
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
por: Hall, Amy B., et al.
Publicado: (2014) -
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
por: Do Carmo, Helison, et al.
Publicado: (2018)